Objective: To identify prognostic survival factors among Mexican women with
cervical cancer. Methods: A total of 378 women with cervical cancer admitt
ed from 1984 to 1996 to our referral hospital were evaluated, using surviva
l analysis (Kaplan-Meier and Cox proportional hazards method). We designed
a symptom index which included asymptomatic conditions, severity of symptom
s and comorbidity. Results: Overall 5-year survival was 66.6%. The shortest
survival time was for FIGO stage IV (21.5%, P < 0.001) and adenosquamous h
istologic type (53.1%, P = 0.15). The main prognostic factors were primary
symptoms (RR, 2.6; 95%a CI, 1.02-6.66); systemic symptoms (RR, 3.3; 95% CI,
1.23-9.01); FIGO stage IV (RR, 5.5; 95% CI, 2.36-12.96); and oncogenic sym
ptoms (prognostic comorbidity present) (RR, 2.3; 95% CI, 1.08-4.89). Conclu
sions: Our findings show that clinical stage and several types of symptoms
influence CC survival. This present strategy to assess morphological and cl
inical characteristics may be a more accurate indicator of survival rate an
d potentially an efficient indicator of new therapeutic alternatives. (C) 2
001 International Federation of Gynecology and Obstetrics. All rights reser
ved.